New injection shows promise for weight loss in early trial
NCT ID NCT06714955
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 21 times
Summary
This early-stage study tested an investigational drug called BGM0504 in 30 non-diabetic adults who were overweight or obese. Participants received multiple doses of the drug or a placebo to check safety and how the body processes it. The main goal was to see if the drug causes any side effects, and researchers also measured weight changes over 10 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-DIABETIC OVERWEIGHT OR OBESE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pharmaron CPC, Inc
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.